Currently, Nathan is President and Chief Executive Officer of Orion Genomics, a St. Louis-based genomics company. He was regionally recognized with the top 40 under 40 award (2004 St. Louis), presented with the Governor’s top technology award (2005 Missouri) and currently serves on the Patient Care Committee of the Board of Missouri Baptist Hospital. Nathan has more than 20 years of experience in genomics. Prior to the founding of Orion Genomics, he was Director of DNA Sequencing at Millennium Pharmaceuticals, Inc., in Cambridge, Massachusetts (1994-98), where he built and operated the DNA sequencing platform for Millennium and helped form three strategic business units – Millennium Predictive Medicine, Millennium Biotherapeutics and Cereon. Before joining Millennium, Nathan held various positions with Molecular Dynamics (Sunnyvale, CA), Ambion (Austin, TX) and Harvard Medical School, Department of Genetics, in the laboratory of George Church. Nathan received a BA in Biochemistry from University of Texas, and an MBA from Washington University Olin School of Business.